These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16552662)

  • 1. Disease management in CKD: panacea or futility?
    Ronco C
    Int J Artif Organs; 2006 Feb; 29(2):153. PubMed ID: 16552662
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs.
    Wei SY; Chang YY; Mau LW; Lin MY; Chiu HC; Tsai JC; Huang CJ; Chen HC; Hwang SJ
    Nephrology (Carlton); 2010 Feb; 15(1):108-15. PubMed ID: 20377778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease management improves ESRD outcomes.
    Sands JJ
    Int J Artif Organs; 2006 Feb; 29(2):154-9. PubMed ID: 16552663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seeking an optimal renal replacement therapy for the chronic kidney disease epidemic: the case for on-line hemodiafiltration.
    Gatti E; Ronco C
    Contrib Nephrol; 2011; 175():170-185. PubMed ID: 22188699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RMS/Bluegrass Family Health Plan partnership improves outcomes, costs.
    Kelly D; Langefeld J
    Nephrol News Issues; 2004 Jun; 18(7):30-4. PubMed ID: 15232995
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost analysis for renal dialysis: Case study from Indochina.
    Joob B; Wiwanitkit V
    Saudi J Kidney Dis Transpl; 2017; 28(4):948. PubMed ID: 28748907
    [No Abstract]   [Full Text] [Related]  

  • 7. Time to move away from damage control strategy in hemodialysis vascular access management: a view from Saudi Arabia.
    Al Wahbi A
    J Vasc Access; 2012; 13(1):1-8. PubMed ID: 21688242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Kidney Disease Initiative and the Division of Diabetes Translation at the Centers for Disease Control and Prevention.
    Albright A; Burrows NR; Jordan R; Williams DE
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S121-5. PubMed ID: 19231756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease management programs for CKD patients: the potential and pitfalls.
    Rocco MV
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S56-63. PubMed ID: 19231762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease management in chronic kidney disease.
    Rastogi A; Linden A; Nissenson AR
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):19-28. PubMed ID: 18155106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact.
    Di Micco L; Torraca S; Pota A; Di Giuseppe D; Pisani A; Spinelli L; De Portu S; Sabbatini M; Mantovani L; Cianciaruso B
    Nephrol Dial Transplant; 2009 Nov; 24(11):3434-40. PubMed ID: 19531671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: Use of renal registry data for research, health-care planning and quality improvement: what can we learn from registry data in the Asia-Pacific region?
    Lim TO; Goh A; Lim YN; Morad Z
    Nephrology (Carlton); 2008 Dec; 13(8):745-52. PubMed ID: 19154324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.
    Collins AJ; Foley RN; Chavers B; Gilbertson D; Herzog C; Johansen K; Kasiske B; Kutner N; Liu J; St Peter W; Guo H; Gustafson S; Heubner B; Lamb K; Li S; Li S; Peng Y; Qiu Y; Roberts T; Skeans M; Snyder J; Solid C; Thompson B; Wang C; Weinhandl E; Zaun D; Arko C; Chen SC; Daniels F; Ebben J; Frazier E; Hanzlik C; Johnson R; Sheets D; Wang X; Forrest B; Constantini E; Everson S; Eggers P; Agodoa L
    Am J Kidney Dis; 2012 Jan; 59(1 Suppl 1):A7, e1-420. PubMed ID: 22177944
    [No Abstract]   [Full Text] [Related]  

  • 14. Health economics and European Renal Best Practice--is it time to bring health economics into evidence-based guideline production in Europe?
    Haller MC; Vanholder R; Oberbauer R; Zoccali C; Van Biesen W
    Nephrol Dial Transplant; 2014 Nov; 29(11):1994-7. PubMed ID: 24009293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for optimal and coordinated management of CKD.
    Levin A
    Kidney Int Suppl; 2005 Dec; (99):S7-10. PubMed ID: 16336580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost.
    Solid CA; Peter SA; Natwick T; Guo H; Collins AJ; Arduino JM
    Nephron; 2017; 136(2):54-61. PubMed ID: 28214902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurse-coordinated care in CKD: time for translation into practice?
    Smith DH; Thorp ML
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1229-31. PubMed ID: 21617089
    [No Abstract]   [Full Text] [Related]  

  • 18. Call to arms….
    Gutekunst L
    J Ren Nutr; 2012 Jan; 22(1):72-4. PubMed ID: 22200417
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost implications of caring for chronic kidney disease: are interventions cost-effective?
    Trivedi H
    Adv Chronic Kidney Dis; 2010 May; 17(3):265-70. PubMed ID: 20439095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International care models for chronic kidney disease: methods and economics--United States.
    Crooks P
    Blood Purif; 2004; 22(1):13-20. PubMed ID: 14732807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.